Eugia recalls an IV antibiotic nationwide over possible glass particles

1 SOURCES UNITED STATESNEW

NOT MEDICAL ADVICE

This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.

BLUF

Eugia is recalling an affected lot of an intravenous antibiotic nationwide because of possible glass particles. The company says using the lot could cause serious harm, including death, according to The Epoch Times.

HOW THIS BRIEF WAS MADE 1 outlet: 1 national. Automated sourcing and summaries by the BLUF engine. Corrections

Why it matters

U.S. patients and health-care providers could be affected if they use the recalled lot; the article does not identify the antibiotic or say how many doses are involved.

What happens next

The article does not specify the lot number, recall instructions, or whether regulators have announced further action.

Which antibiotic and lot are affected

Recall instructions for health-care providers and patients

Any further information from the company or regulators